AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 5

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.24 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019612GHRP-2TFCTFC-2411-A2083Medutest2025-Q199.522.08—Buyer-sourced0PASS
AX-2025-019376GHRP-2HYBHYB-2501-R7240Janoshik2025-Q199.934.8198.6Buyer-sourced0PASS
AX-2025-018674TirzepatideQSCQSC-2410-R5814Janoshik2025-Q199.405.2388.8Buyer-sourced1MARGINAL
AX-2025-018512BPC-157WWBWWB-2502-F3190PeptideMeter2025-Q199.544.69—Buyer-sourced0PASS
AX-2025-018475TirzepatideWWBWWB-2502-U2990PeptideMeter2025-Q199.042.7895.5Buyer-sourced1MARGINAL
AX-2025-018424SemaglutideWWBWWB-2501-S2183Kestrel2025-Q199.504.11—Buyer-sourced0PASS
AX-2025-020295BPC-157GGPepsGGPE-2502-S2559VendorInvestigate2025-Q198.642.85—Buyer-sourced0PASS
AX-2025-018958TirzepatideASYASY-{CAT}-1489Medutest2025-Q198.786.6292.2Buyer-sourced0PASS
AX-2025-018852DihexaFGPFGP-2408-S8496Kestrel2025-Q199.666.59—Laboratory-retained0PASS
AX-2025-018827BPC-157FGPFGP-2409-Y8596Janoshik2025-Q199.565.0597.9Buyer-sourced0PASS
AX-2025-021132EpitalonSIGSIG-2412-6325VendorInvestigate2025-Q199.717.7688.6Buyer-sourced1FAIL
AX-2025-020714IGF-1 LR3SGNSGN-2409-D9295Kestrel2025-Q198.265.59102.0Buyer-sourced0PASS
AX-2025-019686Melanotan IITFCTFC-2410-R2237Janoshik2025-Q199.115.31100.9Buyer-sourced0PASS
AX-2025-019059MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783VendorInvestigate2025-Q198.905.43103.0Buyer-sourced0FAIL
AX-2025-018437SemaglutideWWBWWB-2501-Y2776Medutest2025-Q199.543.85—Buyer-sourced0PASS
AX-2025-018419BPC-157WWBWWB-2408-T2155Janoshik2025-Q199.935.93—Buyer-sourced0PASS
AX-2025-020516MOTS-cSSASSA-2501-M6154PeptideMeter2025-Q198.702.5290.2Supplier-supplied0PASS
AX-2025-020221SemaglutideGGPepsGGPE-2501-W1875VendorInvestigate2025-Q198.575.46—Buyer-sourced1MARGINAL
AX-2025-020069P21SWBSWB-2408-T8372Medutest2025-Q199.408.62103.6Buyer-sourced0PASS
AX-2025-019610GHRP-2TFCTFC-2411-A2083Nordanalyt2025-Q199.842.11102.8Buyer-sourced0PASS
AX-2025-019349TirzepatideHYBHYB-2408-W6301Medutest2025-Q199.103.88—Buyer-sourced3FAIL
AX-2025-018787RetatrutideFGPFGP-2501-S8023Janoshik2025-Q198.764.1397.7Buyer-sourced0PASS
AX-2025-018765BPC-157QSCQSC-2412-D7527Nordanalyt2025-Q199.936.5894.7Buyer-sourced0PASS
AX-2025-018443SemaglutideWWBWWB-2501-Y2776Janoshik2025-Q199.504.2292.6Buyer-sourced0PASS
AX-2025-021148RetatrutideSIGSIG-2411-6312Janoshik2025-Q198.193.6194.8Buyer-sourced0PASS
AX-2025-020599SermorelinSSASSA-2409-X7161Medutest2025-Q198.964.50—Supplier-supplied0PASS
AX-2025-020218SemaglutideGGPepsGGPE-2501-W1875Medutest2025-Q198.396.15—Buyer-sourced0PASS
AX-2025-019647GHRP-2TFCTFC-2502-D2333PeptideMeter2025-Q199.325.4898.6Buyer-sourced0PASS
AX-2025-019004HexarelinASYASY-{CAT}-1786Medutest2025-Q199.823.83106.4Buyer-sourced0PASS
AX-2025-018997HexarelinASYASY-{CAT}-1786Nordanalyt2025-Q199.613.84107.2Buyer-sourced0PASS
AX-2025-018786RetatrutideFGPFGP-2501-S8023Janoshik2025-Q198.994.44—Buyer-sourced0PASS
AX-2025-018446SemaglutideWWBWWB-2501-Y2776Kestrel2025-Q199.783.62100.2Buyer-sourced0PASS
AX-2025-018416SemaglutideWWBWWB-2502-W1846Janoshik2025-Q198.826.62100.3Buyer-sourced1MARGINAL
AX-2025-021134EpitalonSIGSIG-2412-6325Janoshik2025-Q199.018.56—Buyer-sourced0FAIL
AX-2025-020768SemaglutideSGNSGN-2410-D9265Kestrel2025-Q198.374.74100.8Buyer-sourced0PASS
AX-2025-020755PT-141 (Bremelanotide)SGNSGN-2412-Y9108Nordanalyt2025-Q199.276.3593.2Supplier-supplied0PASS
AX-2025-019623SemaglutideTFCTFC-2502-L2101PeptideMeter2025-Q198.393.16104.9Supplier-supplied0PASS
AX-2025-019153LL-37SinoPepSNP-2411-X3762Janoshik2025-Q199.382.1791.6Buyer-sourced1MARGINAL
AX-2025-019142TesamorelinGSPGSP-2501-G3708Medutest2025-Q198.314.5396.0Buyer-sourced0PASS
AX-2025-019121VilonGSPGSP-2411-J3700Medutest2025-Q199.215.52105.6Buyer-sourced0FAIL